NASDAQ: $IONS A Breakthrough for Alexander Disease Patients The landscape for treating ultra-rare genetic disorders has shifted forward. The FDA has officially granted approval for Zanvastro (zilganersen), a pioneering treatment specifically indicated for patients living with Alexander disease (AxD). This approval represents a significant step forward for the medical community and, most importantly, for families…